INSIGHTS ON CLINICAL TRIAL DESIGN
-
![dr vince webinar]( "Effective Study Design And Execution Of Renal And Hepatic Impairment Trials")
Effective Study Design And Execution Of Renal And Hepatic Impairment TrialsMaster the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.
-
![Reusable RTSM Reduces Risk And Speeds Change]( "Reusable RTSM Reduces Risk And Speeds Change")
Reusable RTSM Reduces Risk And Speeds ChangeMinimize human error and accelerate timelines with a reusable software framework. Automation provides deeper testing coverage and faster mid-study updates for more resilient clinical operations.
-
![Automating The Clinical Trial Lifecycle With AI TrialKit]( "Automating The Clinical Trial Lifecycle With AI | TrialKit")
Automating The Clinical Trial Lifecycle With AI | TrialKitAI-driven clinical trials replace manual steps with end-to-end automation, accelerating study setup, cutting costs, and delivering early insights through integrated simulation and analysis.
-
![Supplies Packaging Decisions Start At Clinical Trial Protocol Design]( "Packaging Decisions Start At Clinical Trial Protocol Design")
Packaging Decisions Start At Clinical Trial Protocol DesignA must-watch for anyone optimizing clinical trial IRT workflows, this video explores why clinical supplies should be involved from day one.
-
Strategic CMC Considerations For Pre-IND Meetings: Setting The Stage For A Successful TPP9/1/2025
In biotechnology, the Pre-Investigational New Drug (Pre-IND) stage is a critical juncture. Explore the pivotal role of Chemistry, Manufacturing, and Controls (CMC) in navigating this phase.
-
Rapid Expansion Of Peptide And Nanobody Drug Conjugates7/21/2026
Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.
-
How Sample Issues Can Cause Bioequivalence Studies To Fail7/17/2026
In this webinar excerpt, we learn why biological sample issues can have such an outsized impact in bioequivalence studies.
-
Vendor Selection Bias: Why Structured Decisions Often Fail12/22/2025
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
Leveraging Biomarkers In Early PK/PD Studies7/9/2025
Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![rtsm-clinical-trial-tech-GettyImages-872024272]( "PULSE: Empowering Every Phase of Your Clinical Journey")
A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.
-
![GettyImages-1165576018 clinical solution]( "Clinical Solutions For Early-Phase Drug Development")
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.
-
![GettyImages-1302454470 drug review]( "Why Central IRBs Matter For Efficient Clinical Trials")
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
![GettyImages-1174677845-blood work-blood tubes]( "Precision Kitting: Every Sample Matters, Every Detail Counts")
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
-
![Clinical Trial Recruitment Reinvented]( "Clinical Trial Recruitment Reinvented")
Clinical Site Services (CSS) is the industry leader in delivering strategic patient recruitment and enrollment solutions to study sites, sponsors and CROs.
